Business Wire4d
Omeros Corporation Announces Upcoming Presentations Detailing Outcomes of Narsoplimab Treatment for TA-TMA Under an Expanded Access Program
Omeros Corporation (Nasdaq: OMER) today announced two presentations that will be featured at the 2025 Tandem Meetings – the ...
Nature1y
The immunological relay race: B cells take antigen by synapse
A number of pathogens can initiate the mannan-binding lectin and alternative pathways of complement activation. The classical and alternative pathways of complement activation all tag antigens ...